Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Healthcare professionals’ attitudes towards self-care since the advent of the COVID-19 pandemic

Researchers explored how views/attitudes of health/social care professionals on self-care changed during the COVID-19 pandemic.

2 Mar 2023

Lack of studies limit the integration of artificial intelligence into the clinic

Researchers reviewed the translational success of artificial intelligence models in healthcare, especially those used in COVID-19 studies.

1 Mar 2023

COVID-19 vaccine inequity increased infection and mortality rates in low and middle-income countries

COVID-19 vaccine inequity exists within and between countries, which impacted disease burden and mortality.

1 Mar 2023

Researchers use spatial single-cell transcriptome technique to examine immune signatures of SARS-CoV-2-infected lungs

The study findings demonstrate the power of spatial single-cell transcriptomics in studying COVID-19 lung pathology and other health and disease conditions.

1 Mar 2023

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection

Omicron BTIs induce durable neutralizing immune responses by recalling cross-reactive and vaccine-induced memory B lymphocytes.

1 Mar 2023

New cell-based assay shown to rapidly profile drug resistance to three widely used SARS-CoV-2 main protease inhibiting drugs

In a recent study posted to the bioRxiv* pre-print server, researchers tested three next-generation severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) inhibitors, namely, nirmatrelvir, ensitrelvir, and FB2001, using a novel cell-based assay.

1 Mar 2023

How did people in Zimbabwe respond to drug-resistant tuberculosis alongside COVID-19?

In a recent study posted to the medRxiv* preprint server, researchers described the experiences and coping strategies of people who suffered from drug-resistant tuberculosis (DR-TB) in Zimbabwe between 2020 and 2021.

1 Mar 2023

Omega-3 fatty acids may be protective against contracting or suffering adverse outcomes of COVID-19

A study just published in the American Journal of Clinical Nutrition (AJCN) explored the role of omega-3 fatty acids, especially EPA and DHA, and whether they might be protective against contracting and/or suffering adverse outcomes of COVID-19 infection.

1 Mar 2023

Patterns of new psychiatric diagnoses among children and adolescents during the COVID-19 pandemic

A new study published in PLoS Medicine aimed to determine the number of adolescents and children with primary or secondary diagnoses across the pandemic.

1 Mar 2023

Could spices boost protein intake in older adults?

Poor eating often exacerbates aging problems, resulting in inadequate protein intake among older adults. This, in turn, may cause muscle wasting, reduced function, and poor quality of life. A new research paper looks at the role of spices in boosting the attractiveness of typical foods in this age group.

1 Mar 2023

Evidence that cross-reactive immunity from common human coronaviruses can influence response to SARS-CoV-2

In a recent study published in the journal Vaccines, researchers in Saudi Arabia and the United States examined immune responses and immunoglobulin G (IgG) cross-reactivity in individuals infected with Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Feb 2023

The rapid diagnosis of drug-resistant and drug-sensitive tuberculosis using mass spectrometry and machine learning

In a recent study posted to the Preprints with The Lancet SSRN* server, a team of researchers in China developed a machine learning-based diagnostic tool to detect tuberculosis and drug-resistant tuberculosis using nanoparticle-enhanced laser desorption/ionization mass spectrometry (NPELDI MS) to determine metabolic fingerprints from serum samples.

28 Feb 2023

25% of COVID-19 patients have lasting reduction in lung function

In a recent study posted to the Preprints with The Lancet SSRN* server, researchers evaluated the impairment of pulmonary function in individuals suffering from post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC) or long coronavirus disease (long COVID) symptoms after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

28 Feb 2023

Mass spectrometry-based identification of COVID-19 biomarkers

In a recent study published in the journal Metabolites, researchers reported that mass spectrometry (MS)-based metabolomic approaches have a high potential for biomarker discovery.

28 Feb 2023

Study finds unique epigenetic biosignature in individuals with post-COVID syndrome

A reprogramming of which genes are active, and which are not, is visible in post-COVID sufferers. This is shown in a study from Linköping University, Sweden, on a small group of individuals.

28 Feb 2023

The effects of Omicron emergence on seroprevalence and hybrid immunity in the Finnish adult population

Researchers evaluated SARS-CoV-2 seroprevalence and population-level humoral immunity among Finnish individuals between April 2020 and December 2022.

28 Feb 2023

Economic and life-expectancy losses due to COVID-19 deaths in the United States

A recent study published in Scientific Reports evaluated life expectancy and economic losses due to COVID-19 deaths losses in the United States.

28 Feb 2023

COVID-19 does not increase the risk of Streptococcus pneumoniae infection

SARS-CoV-2 infection does not appear to influence pneumococcal colonization in the upper respiratory tract.

28 Feb 2023

Critical COVID-19 infection characterized by a shift from naïve T cell phenotypes to an expansion of cytotoxic CD4+ T lymphocyte subsets

Researchers immunophenotyped T lymphocyte responses among unvaccinated individuals, representative of the entire spectrum of the clinical presentation of COVID-19.

28 Feb 2023

COVID-19 increases risk of developing chronic diseases

Researchers determine the correlation between severity of SARS-CoV-2 infection, age, and new onset of chronic or worsening of pre-existing conditions.

28 Feb 2023

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Healthcare professionals’ attitudes towards self-care since the advent of the COVID-19 pandemic

Lack of studies limit the integration of artificial intelligence into the clinic

COVID-19 vaccine inequity increased infection and mortality rates in low and middle-income countries

Researchers use spatial single-cell transcriptome technique to examine immune signatures of SARS-CoV-2-infected lungs

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection

New cell-based assay shown to rapidly profile drug resistance to three widely used SARS-CoV-2 main protease inhibiting drugs

How did people in Zimbabwe respond to drug-resistant tuberculosis alongside COVID-19?

Omega-3 fatty acids may be protective against contracting or suffering adverse outcomes of COVID-19

Patterns of new psychiatric diagnoses among children and adolescents during the COVID-19 pandemic

Could spices boost protein intake in older adults?

Evidence that cross-reactive immunity from common human coronaviruses can influence response to SARS-CoV-2

The rapid diagnosis of drug-resistant and drug-sensitive tuberculosis using mass spectrometry and machine learning

25% of COVID-19 patients have lasting reduction in lung function

Mass spectrometry-based identification of COVID-19 biomarkers

Study finds unique epigenetic biosignature in individuals with post-COVID syndrome

The effects of Omicron emergence on seroprevalence and hybrid immunity in the Finnish adult population

Economic and life-expectancy losses due to COVID-19 deaths in the United States

COVID-19 does not increase the risk of Streptococcus pneumoniae infection

Critical COVID-19 infection characterized by a shift from naïve T cell phenotypes to an expansion of cytotoxic CD4+ T lymphocyte subsets

COVID-19 increases risk of developing chronic diseases

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in